Immunai and Teva partner to innovate new cancer, immunology therapies
The collaboration between the two companies reflects ongoing efforts to enhance drug development, the CEO of Immunai said.
Observer3d
How A.I. Is Disrupting Pharma: The High-Stakes Race to Revolutionize Drug Discovery
While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.
Immunai, AstraZeneca collaborate to optimize cancer clinical trials
Immunai Inc., a New York-based artificial intelligence and biotech company specializing in mapping the human immune system, ...
The Times of Israel on MSN1mon
Israeli AI startup forges $18m partnership with AstraZeneca for cancer drug trials
Israeli-American biotech unicorn Immunai on Thursday secured a $18 million partnership to help the Anglo-Swedish pharma giant ...
business-reporter.co.uk1mon
AstraZeneca in AI collaboration with Immunai to inform cancer drug trials
(Reuters) - AstraZeneca will pay $18 million to biotechnology firm Immunai Inc to use the New York-based firm’s AI model of the immune system to make certain cancer drug trials more efficient, the ...